CB21 Pharma extends EU GMP Certification for cannabinoid active pharma ingredients

Manufacturing News Releases

Find the latest News in Manufacturing

Page 31 of 109
CB21 Pharma extends EU GMP Certification for cannabinoid active pharma ingredients
CB21 Pharma extends EU GMP Certification for cannabinoid active pharma ingredients Learn More >
Gasporox demonstrating non-destructive CCIT for parenterals at A3P International Congress Biarritz
Gasporox demonstrating non-destructive CCIT for parenterals at A3P International Congress Biarritz Learn More >
Orano Med Teams Up with Biosynth to Develop Their Next Targeting Vector for Radioligand Therapies
Orano Med Teams Up with Biosynth to Develop Their Next Targeting Vector for Radioligand Therapies Learn More >
HOF Sonderanlagenbau goes on tour of India’s pharma centers
HOF Sonderanlagenbau goes on tour of India’s pharma centers Learn More >
HOF Sonderanlagenbau will be participating at the BioProcess International Conference
HOF Sonderanlagenbau will be participating at the BioProcess International Conference Learn More >
MEDELPHARM host 5th STYL’One User Group Meeting
MEDELPHARM host 5th STYL’One User Group Meeting Learn More >
Mikron showcasing expertise in assembly solution for complex medical devices at Medical Technology Ireland
Mikron showcasing expertise in assembly solution for complex medical devices at Medical Technology Ireland Learn More >
HAPILA and ATHANA alliance receive funding for nanoparticle antifungal program
HAPILA and ATHANA alliance receive funding for nanoparticle antifungal program Learn More >
A-pharmaconsult switches from MDD to MDR
A-pharmaconsult switches from MDD to MDR Learn More >
MEDELPHARM STYL’One Evo DryCon® execution passes FAT and SMEPAC tests
MEDELPHARM STYL’One Evo DryCon® execution passes FAT and SMEPAC tests Learn More >
Körber highlighting pharma shop floor digital AI and MES solutions at Pharma MES Berlin
Körber highlighting pharma shop floor digital AI and MES solutions at Pharma MES Berlin Learn More >
HAPILA’s co-developed anti-TB agent BTZ-043 named ‘Drug of the Year’
HAPILA’s co-developed anti-TB agent BTZ-043 named ‘Drug of the Year’ Learn More >
Page 31 of 109